Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection
Top Cited Papers
- 15 September 2002
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 169 (6) , 3447-3458
- https://doi.org/10.4049/jimmunol.169.6.3447
Abstract
The cellular immune response contributes to clearance of hepatitis C virus (HCV) and persists for decades after recovery from infection. The immunological basis for the inefficiency of the cellular immune response in chronically infected persons is not known. Here, we used four HLA-A2 tetramers, specific for two HCV core and two HCV NS3 epitopes, to investigate at the single-cell level effector function and phenotype of HCV-specific CD8+ T cells in 20 chronically infected and 12 long-term recovered patients. Overall, HCV-specific, tetramer+ T cells were more frequently found in PBMCs of chronically infected patients than in those of recovered patients. However, when compared with HCV-tetramer+ T cells of recovered patients, they displayed an impaired proliferative capacity. As a result of the impaired proliferative capacity, HCV-specific T cell lines derived from chronically infected patients displayed less peptide-specific cytotoxicity than those from recovered patients. In addition, proliferation and ex vivo IFN-γ production of HCV-tetramer+ cells, but not influenza-virus-specific T cells, were defective in chronically infected patients and could not be restored by in vitro stimulation with peptide and IL-2. At least three distinct phenotypes of HCV-specific CD8+ T cells were identified and associated with certain functional characteristics. In addition, impairment of proliferative, cytokine, and cytotoxic effector functions of tetramer+ T cells in viremic patients was associated with weak ex vivo HCV-specific CD4+ T cell responses. Thus, the defective functions of HCV-specific CD8+ T cells might contribute to viral persistence in chronically infected patients, and knowledge on their reversibility may facilitate the development of immunotherapeutic vaccines.Keywords
This publication has 67 references indexed in Scilit:
- Escaping High Viral Load ExhaustionThe Journal of Experimental Medicine, 2002
- HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic FunctionThe Journal of Experimental Medicine, 2000
- Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: A 20-year multicenter studyHepatology, 2000
- Association of Hepatitis C Virus–Specific CD8+T Cells with Viral Clearance in Acute Hepatitis CThe Journal of Infectious Diseases, 2000
- Cd40-Independent Pathways of T Cell Help for Priming of Cd8+ Cytotoxic T LymphocytesThe Journal of Experimental Medicine, 2000
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Phenotypic and Functional Separation of Memory and Effector Human CD8+ T CellsThe Journal of Experimental Medicine, 1997
- Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.Journal of Clinical Investigation, 1995
- CD27: marker and mediator of T-cell activation?Immunology Today, 1994
- Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4Nature, 1991